In Vitro Antibacterial Experiment of Fuzheng Jiedu Huayu Decoction Against Multidrug-Resistant Pseudomonas aeruginosa

被引:16
|
作者
Xu, Hongri [1 ]
Liu, Chang [2 ]
Li, Meng [3 ]
Wang, Chengxiang [2 ]
Liu, Guoxing [2 ]
Wang, Honghong [1 ]
Ma, Jie [4 ]
Li, Lei [2 ]
Chen, Meng [5 ]
Cheng, Miao [6 ]
Yao, Xingwei [7 ]
Lin, Ying [7 ]
Zhao, Shitong [6 ]
Wang, Yuting [6 ]
Wang, Mingzhe [8 ]
机构
[1] Beijing Univ Chinese Med BUCM, Affiliated Hosp 3, Emergency Dept, Beijing, Peoples R China
[2] BUCM Third Affiliated Hosp, Resp Dept, Beijing, Peoples R China
[3] ShaanXi Tradit Chinese Med TCM Hosp, Resp Dept, Xian, Peoples R China
[4] Beijing Hosp Integrated Tradit Chinese & Western, Resp Dept, Beijing, Peoples R China
[5] China Acad Inspect & Quarantine, Inst Ind & Consumer Prod Safety, Beijing, Peoples R China
[6] Dongzhimen Hosp Affiliated BUCM, Resp Dept, Beijing, Peoples R China
[7] Dongzhimen Hosp Affiliated BUCM, Clin Lab, Beijing, Peoples R China
[8] China Japan Friendship Hosp, Resp Dept, Beijing, Peoples R China
来源
FRONTIERS IN PHARMACOLOGY | 2020年 / 10卷
基金
中国国家自然科学基金; 高等学校博士学科点专项科研基金;
关键词
growth curve; Fuzheng Jiedu Huayu decoction; multidrug-resistant Pseudomonas aeruginosa; in vitro antibacterial; drug sensitivity test;
D O I
10.3389/fphar.2019.01682
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective Drawing a growth curve of multidrug-resistant Pseudomonas aeruginosa (MDR-PA) provides a foundation for susceptibility testing. By observing in vitro antibacterial activity and ultrastructure cthanges on MDR-PA of the effective components in the drug-containing serum of rats after the administration of Fuzheng Jiedu Huayu decoction (FJHD), we evaluated the inhibition and direct destruction effect of bacteria by TCM alone or combined with antibiotics. Methods The absorbance values of MDR-PA were determined at different detection time points, and a growth curve was drawn. After gavage with FJHD, drug-containing serum was collected from the rats. Using Imipenem/cilastatin sodium as the positive drug control, the in vitro antibacterial potency of FJHD and its drug-containing serum alone or in combination with antibiotics against MDR-PA was observed. The ultrastructural changes of MDR-PA treated by FJHD combined with antibiotics were observed by transmission electron microscopy. Results Growth of the experimental strain manifested a lag phase in the first 1-4 h, an exponential growth phase at 5-20 h, and a plateau phase after 20 h. The best detection time during the susceptibility test was 16-20 h. The minimum inhibitory concentration (MIC) value of the FJHD extract group was 0.2 g/mL. The MIC value of the pure Imipenem/cilastatin sodium group was 16 mu g/mL. The MIC values of Imipenem/cilastatin sodium + blank serum, 0.5-, 1-, and 2-fold drug-containing serum groups were all 16 mu g/mL. The MIC values of Imipenem/cilastatin sodium + 4- and 8-fold drug-containing serum groups were both 8 mu g/mL. By observation under a transmission electron microscope, Imipenem/cilastatin sodium + 0.5-, 1-, and 2-fold drug-containing serum groups showed bacterial structural damage. The degree of bacterial destruction was more obvious and the quantity of damaged bacteria was increased in the Imipenem/cilastatin sodium + 4- and 8-fold drug-containing serum groups. Conclusion Drawing the growth curve of the experimental strain had high application value for ensuring the accuracy of the drug sensitivity test results. TCM combined with antibiotics could enhance the antibacterial and direct destruction effect of bacteria in vitro, thereby inhibiting bacterial resistance to a certain extent.
引用
收藏
页数:11
相关论文
共 36 条
  • [1] Aspirin enhances the antibacterial activity of colistin against multidrug-resistant Pseudomonas aeruginosa
    Zhang, Ning
    Li, Xue
    Liu, Xin
    Cheng, Ping
    Li, Lailai
    Chai, Yihui
    Cao, Mingle
    Yang, Yuqi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 997
  • [2] In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa
    Yamagishi, Yuka
    Hagihara, Mao
    Kato, Hideo
    Hirai, Jun
    Nishiyama, Naoya
    Koizumi, Yusuke
    Sakanashi, Daisuke
    Suematsu, Hiroyuki
    Nakai, Hazuki
    Mikamo, Hiroshige
    CHEMOTHERAPY, 2017, 62 (02) : 105 - 110
  • [3] Synergistic and antibiofilm properties of ocellatin peptides against multidrug-resistant Pseudomonas aeruginosa
    Bessa, Lucinda J.
    Eaton, Peter
    Dematei, Anderson
    Placido, Alexandra
    Vale, Nuno
    Gomes, Paula
    Delerue-Matos, Cristina
    Leite, Jose Roberto S. A.
    Gameiro, Paula
    FUTURE MICROBIOLOGY, 2018, 13 (02) : 151 - 163
  • [4] Bactericidal Activity in Filtrated Supernatant of Streptococcus Sanguinis against Multidrug-Resistant Pseudomonas Aeruginosa
    Watanabe, Kiwao
    Senba, Masachika
    Ichinose, Akitoyo
    Yamamoto, Takeshi
    Ariyoshi, Koya
    Matsumoto, Keizo
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 219 (02) : 79 - 84
  • [5] Bactericidal efficacy of cold atmospheric plasma treatment against multidrug-resistant Pseudomonas aeruginosa
    Wang, Liyun
    Xia, Chuankai
    Guo, Yajun
    Yang, Chunjun
    Cheng, Cheng
    Zhao, Jun
    Yang, Xingyu
    Cao, Zhicheng
    FUTURE MICROBIOLOGY, 2020, 15 (02) : 115 - 125
  • [6] Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection
    Viasus, D.
    Puerta-Alcalde, P.
    Cardozo, C.
    Suarez-Lledo, M.
    Rodriguez-Nunez, O.
    Morata, L.
    Feher, C.
    Marco, F.
    Chumbita, M.
    Moreno-Garcia, E.
    Fernandez-Aviles, F.
    Gutierrez-Garcia, G.
    Martinez, J. A.
    Mensa, J.
    Rovira, M.
    Esteve, J.
    Soriano, A.
    Garcia-Vidal, C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (03) : 345 - 350
  • [7] Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam
    Hernandez-Tejedor, Alberto
    Debora Merino-Vega, Carmen
    Martin-Vivas, Alfredo
    Ruiz de Luna-Gonzalez, Rafael
    Delgado-Iribarren, Alberto
    Gaban-Diez, Angeles
    Temprano-Gomez, Ignacio
    de la Calle-Pedrosa, Natalia
    Isabel Gonzalez-Jimenez, Ana
    Algora-Weber, Alejandro
    INFECTION, 2017, 45 (01) : 115 - 117
  • [8] Antimicrobial Potentialities of Streptomyces lienomycini NEAE-31 Against Human Pathogen Multidrug-resistant Pseudomonas aeruginosa
    El-Naggar, Noura El-Ahmady Ali
    Hamouda, Ragaa A.
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2016, 12 (08) : 769 - 788
  • [9] Risk Factors for Multidrug-resistant Pseudomonas aeruginosa Among Hospitalized Patients at a Malaysian Hospital
    Nasir, M. D. Mohd
    Nurnajwa, M. H.
    Lay, J.
    Teoh, J. C.
    Syafinaz, A. N.
    Niazlin, M. T.
    SAINS MALAYSIANA, 2015, 44 (02): : 257 - 260
  • [10] An Efficient and Novel Screening Model for Assessing the Bioactivity of Extracts against Multidrug-Resistant Pseudomonas aeruginosa Using Caenorhabditis elegans
    Zhou, Yu-meng
    Shao, Lei
    Li, Ji-an
    Han, Li-zhong
    Cai, Wai-jiao
    Zhu, Chun-bao
    Chen, Dai-jie
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2011, 75 (09) : 1746 - 1751